ara 290 vs bpc-157 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes | Molecular Medicine BPC-157 Peptide | 99%+ Purity,
Description
Potential Research Applications: Neuroprotection and brain-gut axis studies Pulmonary function and airway inflammation models Immune system modulation and anti-inflammatory research Gastrointestinal motility and secretory regulation For laboratory research only
Taken together, these observations suggest that hyperhomocysteinemia favors thrombogenesis
Benefits Soothes Hydrates Protects the skin Luxurious, non-greasy formula
Hoping for good results
(2008) Biomaterials Study examining AOD 9604 effects on vascular endothelial growth factor production and neovascularization in engineered cartilage
